Stoke Therapeutics (STOK) Q1 2023 Earnings

4MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.7
-0.64
-0.59
-0.53

Details

Expected EPS
-0.69
Actual EPS
-0.53
Surprise EPS
0.16
Surprise Percent
+23.19%

Description

Stoke Therapeutics (STOK) has reported earnings of -0.53 per share for Q1 2023.

0 Comments

Share your thoughts